Latest News - Fillers & Injectables

Tuesday, December 05, 2017 | Phase 3/4 Trials, PracticalDermatology.com, Research and Publications

Revance: RT002 Achieves 6-Month Duration in Phase 3

  Revance Therapeutics’ next-generation neuromodulator DaxibotulinumtoxinA for Injection (RT002) delivered positive top-line results in alleviating moderate-to-severe glabellar lines in …

Read the full story

Thursday, November 30, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Practice Development, Cosmetic surgery

9th Annual Cosmetic Surgery Forum Kicks Off in Las Vegas

Cosmetic Surgery Forum 2017, now in its ninth year, got underway with a Director’s Welcome Reception on Wednesday, November 29 at the Bellagio Hotel & Casino in Las Vegas. And this year…

Read the full story

Monday, November 20, 2017 | Personnel/Company News, PracticalDermatology.com, Product Launches and Updates

Milestone Scientific Set To Launch New Botox Delivery Instrument

Botulinum toxin injections may be about to get smarter and more comfortable as Milestone Scientific Inc. gears up to launch its novel and proprietary cosmetic injection instrument. The new cosmetic…

Read the full story

Thursday, October 12, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates, Galderma

FDA Approves Injection of Restylane Silk via Cannula for Lip Augmentation

The FDA has approved the use of a small blunt tip cannula with Galderma's Restylane Silk for lip augmentation. Restylane Silk was the first FDA-approved hyaluronic acid (HA) dermal filler specific…

Read the full story

Monday, October 09, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, American Society for Dermatologic Surgery

And the ASDS Stegman Award Goes to … Susan H. Weinkle, MD

Bradenton, FL-based dermatologist Susan H. Weinkle, MD received the Samuel J. Stegman, MD, Award for Distinguished Service at The American Society for Dermatologic Surgery (ASDS) 2017 Annual Meet…

Read the full story

Friday, October 06, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, American Society for Dermatologic Surgery

Lisa M. Donofrio, MD Takes Reins of ASDS/ASDSA

Lisa M. Donofrio, MD, is the new President of the American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA). Along with her fellow officers …

Read the full story

Tuesday, September 12, 2017 | Personnel/Company News, PracticalDermatology.com, Product Launches and Updates, Allergan , SkinMedica, Zeltiq

Allergan Adds Coolsculpting, Other Bells and Whistles to Brilliant Distinctions® Patient Loyalty Program

Allergan is launching the next generation of its U.S.-based Brilliant Distinctions® program. The new offering incorporates digital innovation to enhance the consumer experience and drive increa…

Read the full story

Friday, September 08, 2017 | Personnel/Company News, PracticalDermatology.com, Allergan

Deion Sanders Named Brand Ambassador for Botox Cosmetic

NFL analyst and philanthropist Deion Sanders, the only athlete to play in both the Super Bowl™ and World Series™, is the new brand ambassador for BOTOX® Cosmetic. Allergan…

Read the full story

Thursday, September 07, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, Galderma

Galderma Names New Managers of Prescription Business and Aesthetic & Corrective Business Units; Dr. Kelly Huang to Obalon

Galdmera has named new managers of its Prescription Business and Aesthetic & Corrective Business units in the United States. Chris Chapman is Galderma’s new Vice President and General Manage…

Read the full story

Wednesday, August 09, 2017 | PracticalDermatology.com, Product Launches and Updates, Research and Publications

Bonti’s Novel Gateway Neuromodulator Performs Well in Phase 2A Study

Bonti’s lead product candidate, EB- 001, passed muster in a Phase 2A study for the treatment of glabellar lines. EB-001 is a novel serotype E botulinum neurotoxin with a unique efficacy profi…

Read the full story

Wednesday, July 12, 2017 | Personnel/Company News, PracticalDermatology.com, Allergan

Allergan CEO: Consensus Needed on Medical Aesthetic Treatment in Minors

Allergan Chairman & CEO Brent Saunders, the father of two high school-aged girls, is speaking up and out about the risks associated with offering medical aesthetic treatments to minors. In a ne…

Read the full story

Tuesday, June 27, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications, American Society for Dermatologic Surgery

ASDS: Percentage of Us Wanting Cosmetic Surgery Doubled Since 2013

Nearly 70 percent of consumers now say they are thinking about getting a cosmetic treatment, according to survey data released by the American Society for Dermatologic Surgery (ASDS). The ASDS Cons…

Read the full story

Monday, June 26, 2017 | PracticalDermatology.com

Thumbs Down for Neothetics, Inc.’s LIPO-202; Stock Plummets

Neothetics, Inc.’s LIPO-202 for the reduction of submental subcutaneous fat failed to demonstrate improvement on any efficacy measurements or separation from placebo in a Phase 2 proof-of-c…

Read the full story

Tuesday, May 30, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, American Society for Dermatologic Surgery

ASDS: Nearly 10.5 Million Treatments Performed in 2016

Dermatologic surgeons performed nearly 10.5 million medically necessary and cosmetic procedures in 2016 -- five percent more than 2015 and up 31 percent since 2012, according to the 2016 American So…

Read the full story

Thursday, April 06, 2017 | Phase 3/4 Trials, PracticalDermatology.com, Galderma

Phase 4 Studies of Restylane® Refyne and Restylane® Defyne Show Lasting Natural Benefit

Two Phase 4 clinical studies of Restylane® Refyne and Restylane® Defyne show that the natural-looking results last. Specifically, the Natural Expression study found that…

Read the full story
Load More